---
title: "Chemring director Sarah Ellard trims shareholding in disclosed sale"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294709227.md"
description: "Chemring director Sarah Ellard sold 57,597 shares for approx. £347,000 on Aug 3, 2026, retaining 210,000 shares. This disclosure complies with PDMR regulations. While reducing her direct exposure, she maintains a substantial holding. Analysts rate the stock as 'Buy' with a £660 target, though AI analysis suggests 'Neutral' due to mixed technical signals and valuation concerns."
datetime: "2026-08-03T14:37:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294709227.md)
  - [en](https://longbridge.com/en/news/294709227.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294709227.md)
generator: "portal-rs"
---

# Chemring director Sarah Ellard trims shareholding in disclosed sale

An update from Chemring ( (GB:CHG) ) is now available.

Chemring Group has disclosed that board director and PDMR Sarah Ellard sold 57,597 ordinary 1p shares in the company on 3 August 2026 in London at an average price of about 602p, raising approximately £347,000. Following the transaction, Ellard retains an interest in 210,000 Chemring shares, and the dealing has been reported in line with regulatory requirements for senior management share transactions.

The sale slightly reduces a director’s direct exposure to Chemring equity but leaves her with a substantial continuing shareholding, which may reassure investors about ongoing alignment with shareholders. The announcement underscores Chemring’s adherence to market disclosure rules on PDMR dealings, providing transparency around insider share sales to the company’s stakeholders.

The most recent analyst rating on (GB:CHG) stock is a Buy  
 with a £660.00 price target.  
 To see the full list of analyst forecasts on Chemring stock,  
 see the GB:CHG Stock Forecast page. 

**Spark’s Take on CHG Stock**

According to Spark, TipRanks’ AI Analyst, CHG is a Neutral.

The score is primarily supported by solid profitability and a manageable balance sheet, but is held back by weakening revenue growth and notably pressured free cash flow. Technical signals are mixed with negative MACD and a weaker longer-term trend, and valuation is a meaningful drag due to the high P/E with only a modest dividend yield.

To see Spark’s full report on CHG stock,  
 click here. 

**More about Chemring**

Chemring Group is a UK-listed defence and aerospace company that manufactures countermeasures, sensors, and related technologies for military and security customers. The group focuses on supplying mission-critical products to governments and defence organisations, with its shares traded on the London market.

**Average Trading Volume:** 1,415,158

**Technical Sentiment Signal:** Strong Buy

**Current Market Cap:** £1.6B

For a thorough assessment of CHG stock, go to TipRanks’ Stock Analysis page.

### Related Stocks

- [CHG.UK](https://longbridge.com/en/quote/CHG.UK.md)

## Related News & Research

- [REG - Chemring Group PLC - Director/PDMR Shareholding](https://longbridge.com/en/news/294917248.md)
- [REG - Chemring Group PLC - Director/PDMR Shareholding](https://longbridge.com/en/news/294709296.md)
- [Chemring Clarifies Voting Share Capital for Regulatory Disclosure](https://longbridge.com/en/news/294649263.md)
- [Berenberg Bank Reaffirms Their Buy Rating on Chemring (CHG)](https://longbridge.com/en/news/294667755.md)
- [REG - Chemring Group PLC - Holding(s) in Company](https://longbridge.com/en/news/294842012.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**